Ambarella, Inc. AMBA
72.68
2.82
4.04%
as of 25 Sep
- Market cap
- $3.1B
- P/E
- 0.0×
Follow AMBA
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
9.06 | 7.40 | 6.87 | 9.77 | |
P/FCF ratio |
0.00 | 1,101.34 | 63.12 | 74.85 | |
P/Operating CF |
(14,555.70) | (117.07) | 142.09 | 106.47 | |
P/B ratio |
6.10 | 4.95 | 4.51 | 6.19 | |
Price to Tangible BV |
14.55 | 12.34 | 11.52 | 14.70 | |
EV/Sales |
8.41 | 6.72 | 6.07 | 8.98 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
128.51 | 82.25 | 32.27 | 41.95 | |
EV/FCF |
(611.69) | 999.19 | 55.76 | 68.79 | |
Quick Ratio |
2.24 | 1.90 | 1.98 | 2.34 | |
Current Ratio |
2.85 | 2.43 | 2.31 | 2.66 | |
Net Debt/EBITDA |
157.04 | 21.31 | 24.56 | 30.29 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.56 | 0.54 | 0.53 | 0.53 | |
Operating CF/Net income |
0.04 | 1.42 | (1.15) | (2.27) | |
Capex/Depreciation |
(1.06) | (0.62) | (0.69) | (0.45) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
46.78% | 57.93% | 58.01% | 56.66% | |
Selling, General and Administrative Expense of Revenue |
18.48% | 19.79% | 18.67% | 17.87% | |
Intangible Assets out of Total Assets |
0.46 | 0.46 | 0.45 | 0.45 | |
Share Based Compensation of Revenue |
20.99% | 21.82% | 20.80% | 23.73% | |
Graham Net Nets |
0.06 | 0.07 | 0.08 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.50%) | (2.34%) | (2.83%) | (2.21%) | |
Free Cash Flow Yield |
(0.15%) | 0.09% | 1.58% | 1.34% | |
Revenue per Share |
2.46 | 2.30 | 2.36 | 2.53 | |
Operating CF per Share |
(0.01) | (0.59) | 0.44 | 0.80 | |
Capex per Share |
(0.15) | (0.09) | (0.09) | (0.07) | |
Free Cash Flow per Share |
(0.16) | (0.68) | 0.35 | 0.73 | |
Cash per Share |
6.20 | 6.38 | 7.33 | 6.90 | |
Shareholders Equity per Share |
14.10 | 13.89 | 13.93 | 13.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.10 | 13.89 | 13.93 | 13.77 | |
Free Cash Flow |
(7.08) | (29.58) | 14.97 | 31.41 | |
Working Capital |
255.65 | 238.23 | 232.33 | 239.21 | |
Capital Expenditures |
(6.82) | (3.96) | (3.92) | (2.90) | |
Net Current Asset Value |
234.13 | 216.17 | 206.46 | 221.89 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.06 | 0.04 | 0.04 | 0.03 | |
Net Profit Margin |
(6.19%) | (18.03%) | (16.29%) | (13.93%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
40.17 | 34.71 | 34.47 | 38.10 | |
Average Payables |
26.63 | 44.28 | 37.90 | 30.08 | |
Average Inventory |
55.37 | 59.82 | 43.34 | 37.88 | |
Average Assets |
743.32 | 748.38 | 743.78 | 711.34 | |
Average Common Equity |
598.42 | 589.27 | 578.10 | 572.20 |
Columns are period end dates